US FDA Approves Abbott's Amplatzer Paraclose PVL Occluder for Heart Valve Leaks

The U.S. Food and Drug Administration (FDA) has approved Abbott's Amplatzer Paraclose PVL Occluder, making it the first and only transcatheter device specifically designed to treat paravalvular leak (PVL). PVL is a condition where blood leaks around a surgically replaced heart valve, potentially leading to symptoms such as shortness of breath, fatigue, and anemia. This minimally invasive treatment provides an alternative to additional open-heart surgery for affected patients.